Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering
Business Wire•29/09/2026•08:00 ET
0
Key Highlights
- ➤Lantern Pharma (LTRN) prices 3,669,725 shares at $1.09 per share.
- ➤Offering generates approximately $4 million in upfront gross proceeds.
- ➤Warrants could generate an additional approximately $4 million if fully exercised.
- ➤Warrants cover 3,669,725 shares at a $1.09 exercise price.
- ➤Proceeds intended for working capital and general corporate purposes.
Lantern Pharma Inc. Announces up to $8 Million Registered Direct Offering
$4 million upfront with up to an additional $4 million of potential aggregate gross proceeds upon the exercise in full of the warrants
Get started
Create a free account to read the full story.